Riboflavin Corneal Crosslinking
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Riboflavin Corneal Crosslinking, covering 2011-03-03 to 2011-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VI [NA]